Liquidia Co. (NASDAQ:LQDA – Get Free Report) General Counsel Russell Schundler sold 16,393 shares of the company’s stock in a transaction that occurred on Tuesday, January 14th. The stock was sold at an average price of $11.78, for a total transaction of $193,109.54. Following the transaction, the general counsel now owns 573,478 shares in the company, valued at $6,755,570.84. The trade was a 2.78 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which is available through this link.
Russell Schundler also recently made the following trade(s):
- On Monday, December 2nd, Russell Schundler sold 1,063 shares of Liquidia stock. The stock was sold at an average price of $11.51, for a total transaction of $12,235.13.
Liquidia Price Performance
NASDAQ:LQDA traded down $0.40 during mid-day trading on Tuesday, reaching $11.36. 552,977 shares of the company’s stock traded hands, compared to its average volume of 728,753. Liquidia Co. has a 12-month low of $8.26 and a 12-month high of $16.99. The firm has a market capitalization of $961.48 million, a price-to-earnings ratio of -6.97 and a beta of 0.23. The company has a 50 day moving average price of $11.18 and a 200-day moving average price of $11.02.
Analyst Ratings Changes
Get Our Latest Stock Analysis on Liquidia
Institutional Trading of Liquidia
A number of hedge funds have recently made changes to their positions in LQDA. Quest Partners LLC bought a new position in Liquidia in the 2nd quarter valued at approximately $27,000. Clear Harbor Asset Management LLC purchased a new stake in shares of Liquidia in the 3rd quarter worth $100,000. Signaturefd LLC increased its stake in shares of Liquidia by 38,400.0% in the 3rd quarter. Signaturefd LLC now owns 10,010 shares of the company’s stock worth $100,000 after purchasing an additional 9,984 shares in the last quarter. Ballentine Partners LLC purchased a new stake in shares of Liquidia in the 3rd quarter worth $110,000. Finally, Whitcomb & Hess Inc. boosted its holdings in Liquidia by 10.2% in the 3rd quarter. Whitcomb & Hess Inc. now owns 11,599 shares of the company’s stock worth $116,000 after buying an additional 1,074 shares during the period. 64.54% of the stock is owned by institutional investors.
About Liquidia
Liquidia Corporation, a biopharmaceutical company, develops, manufactures, and commercializes various products for unmet patient needs in the United States. Its lead product candidates include YUTREPIA, an inhaled dry powder formulation of treprostinil for the treatment of pulmonary arterial hypertension (PAH) and pulmonary hypertension associated with interstitial lung disease (PH-ILD).
Further Reading
- Five stocks we like better than Liquidia
- EV Stocks and How to Profit from Them
- The Fed Is More Likely to Hike Than Cut Rates in 2025
- What Are Dividend Challengers?
- Investors Navigate Uncertainty by Seeking Refuge in Gold and Oil
- P/E Ratio Calculation: How to Assess Stocks
- Archer Aviation Shares Slide, Now Bargain Priced for 2025
Receive News & Ratings for Liquidia Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Liquidia and related companies with MarketBeat.com's FREE daily email newsletter.